Logo image of 3QD.DE

DATADOG INC - CLASS A (3QD.DE) Stock Fundamental Analysis

FRA:3QD - Deutsche Boerse Ag - US23804L1035 - Common Stock - Currency: EUR

140.32  +2.44 (+1.77%)

Fundamental Rating

5

3QD gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 98 industry peers in the Software industry. No worries on liquidiy or solvency for 3QD as it has an excellent financial health rating, but there are worries on the profitability. 3QD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

3QD had positive earnings in the past year.
3QD had a positive operating cash flow in the past year.
In the past 5 years 3QD reported 4 times negative net income.
3QD had a positive operating cash flow in each of the past 5 years.
3QD.DE Yearly Net Income VS EBIT VS OCF VS FCF3QD.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 200M 400M 600M

1.2 Ratios

3QD has a Return On Assets (4.15%) which is in line with its industry peers.
Looking at the Return On Equity, with a value of 7.31%, 3QD is in line with its industry, outperforming 55.17% of the companies in the same industry.
The Return On Invested Capital of 3QD (2.05%) is comparable to the rest of the industry.
Industry RankSector Rank
ROA 4.15%
ROE 7.31%
ROIC 2.05%
ROA(3y)-0.44%
ROA(5y)-0.84%
ROE(3y)-1.05%
ROE(5y)-1.57%
ROIC(3y)N/A
ROIC(5y)N/A
3QD.DE Yearly ROA, ROE, ROIC3QD.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 -5 -10 -15

1.3 Margins

3QD has a Profit Margin (7.58%) which is comparable to the rest of the industry.
Looking at the Operating Margin, with a value of 2.86%, 3QD is doing worse than 62.07% of the companies in the same industry.
With a decent Gross Margin value of 81.22%, 3QD is doing good in the industry, outperforming 72.41% of the companies in the same industry.
3QD's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.86%
PM (TTM) 7.58%
GM 81.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y1.09%
3QD.DE Yearly Profit, Operating, Gross Margins3QD.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

8

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so 3QD is destroying value.
The number of shares outstanding for 3QD has been increased compared to 1 year ago.
The number of shares outstanding for 3QD has been increased compared to 5 years ago.
3QD has a better debt/assets ratio than last year.
3QD.DE Yearly Shares Outstanding3QD.DE Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M
3QD.DE Yearly Total Debt VS Total Assets3QD.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.2 Solvency

An Altman-Z score of 15.88 indicates that 3QD is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 15.88, 3QD belongs to the top of the industry, outperforming 95.40% of the companies in the same industry.
3QD has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.01
Altman-Z 15.88
ROIC/WACC0.19
WACC10.9%
3QD.DE Yearly LT Debt VS Equity VS FCF3QD.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.13 indicates that 3QD has no problem at all paying its short term obligations.
3QD has a better Current ratio (2.13) than 77.01% of its industry peers.
3QD has a Quick Ratio of 2.13. This indicates that 3QD is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.13, 3QD is in the better half of the industry, outperforming 78.16% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.13
Quick Ratio 2.13
3QD.DE Yearly Current Assets VS Current Liabilites3QD.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

9

3. Growth

3.1 Past

3QD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.26%, which is quite impressive.
Measured over the past years, 3QD shows a very strong growth in Earnings Per Share. The EPS has been growing by 95.35% on average per year.
The Revenue has grown by 26.30% in the past year. This is a very strong growth!
The Revenue has been growing by 60.78% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)39.26%
EPS 3Y95.35%
EPS 5YN/A
EPS Q2Q%2.22%
Revenue 1Y (TTM)26.3%
Revenue growth 3Y52.21%
Revenue growth 5Y60.78%
Sales Q2Q%26.02%

3.2 Future

The Earnings Per Share is expected to grow by 22.47% on average over the next years. This is a very strong growth
3QD is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 23.13% yearly.
EPS Next Y10.96%
EPS Next 2Y12.89%
EPS Next 3Y15.59%
EPS Next 5Y22.47%
Revenue Next Year26.29%
Revenue Next 2Y23.9%
Revenue Next 3Y23.42%
Revenue Next 5Y23.13%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
3QD.DE Yearly Revenue VS Estimates3QD.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
3QD.DE Yearly EPS VS Estimates3QD.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6 8 10

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 77.10, which means the current valuation is very expensive for 3QD.
The rest of the industry has a similar Price/Earnings ratio as 3QD.
The average S&P500 Price/Earnings ratio is at 28.58. 3QD is valued rather expensively when compared to this.
3QD is valuated quite expensively with a Price/Forward Earnings ratio of 69.39.
3QD's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. 3QD is more expensive than 71.26% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 95.03. 3QD is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 77.1
Fwd PE 69.39
3QD.DE Price Earnings VS Forward Price Earnings3QD.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 3QD indicates a slightly more expensive valuation: 3QD is more expensive than 77.01% of the companies listed in the same industry.
3QD's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 66.99
EV/EBITDA 354.65
3QD.DE Per share data3QD.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
3QD's earnings are expected to grow with 15.59% in the coming years. This may justify a more expensive valuation.
PEG (NY)7.04
PEG (5Y)N/A
EPS Next 2Y12.89%
EPS Next 3Y15.59%

0

5. Dividend

5.1 Amount

3QD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

DATADOG INC - CLASS A

FRA:3QD (2/4/2025, 7:00:00 PM)

140.32

+2.44 (+1.77%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-13 2025-02-13/amc
Inst Owners82.6%
Inst Owner ChangeN/A
Ins Owners3.14%
Ins Owner ChangeN/A
Market Cap47.67B
Analysts83.6
Price Target157.71 (12.39%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.79%
Min EPS beat(2)12.91%
Max EPS beat(2)14.67%
EPS beat(4)4
Avg EPS beat(4)18.68%
Min EPS beat(4)12.91%
Max EPS beat(4)23.78%
EPS beat(8)8
Avg EPS beat(8)22.25%
EPS beat(12)12
Avg EPS beat(12)36.63%
EPS beat(16)16
Avg EPS beat(16)66.66%
Revenue beat(2)2
Avg Revenue beat(2)1.56%
Min Revenue beat(2)1.29%
Max Revenue beat(2)1.83%
Revenue beat(4)4
Avg Revenue beat(4)1.53%
Min Revenue beat(4)1.29%
Max Revenue beat(4)1.83%
Revenue beat(8)7
Avg Revenue beat(8)1.45%
Revenue beat(12)11
Avg Revenue beat(12)2.91%
Revenue beat(16)15
Avg Revenue beat(16)3.77%
PT rev (1m)0.75%
PT rev (3m)13.37%
EPS NQ rev (1m)0.14%
EPS NQ rev (3m)11.77%
EPS NY rev (1m)0.01%
EPS NY rev (3m)7.92%
Revenue NQ rev (1m)0.09%
Revenue NQ rev (3m)0.22%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.12%
Valuation
Industry RankSector Rank
PE 77.1
Fwd PE 69.39
P/S 19.43
P/FCF 66.99
P/OCF 59.67
P/B 18.74
P/tB 21.69
EV/EBITDA 354.65
EPS(TTM)1.82
EY1.3%
EPS(NY)2.02
Fwd EY1.44%
FCF(TTM)2.09
FCFY1.49%
OCF(TTM)2.35
OCFY1.68%
SpS7.22
BVpS7.49
TBVpS6.47
PEG (NY)7.04
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.15%
ROE 7.31%
ROCE 2.55%
ROIC 2.05%
ROICexc N/A
ROICexgc N/A
OM 2.86%
PM (TTM) 7.58%
GM 81.22%
FCFM 29%
ROA(3y)-0.44%
ROA(5y)-0.84%
ROE(3y)-1.05%
ROE(5y)-1.57%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.97%
GM growth 5Y1.09%
F-Score6
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.01
Debt/EBITDA 0
Cap/Depr 175.76%
Cap/Sales 3.55%
Interest Coverage 250
Cash Conversion 666.23%
Profit Quality 382.77%
Current Ratio 2.13
Quick Ratio 2.13
Altman-Z 15.88
F-Score6
WACC10.9%
ROIC/WACC0.19
Cap/Depr(3y)161.71%
Cap/Depr(5y)168.19%
Cap/Sales(3y)3.44%
Cap/Sales(5y)4.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.26%
EPS 3Y95.35%
EPS 5YN/A
EPS Q2Q%2.22%
EPS Next Y10.96%
EPS Next 2Y12.89%
EPS Next 3Y15.59%
EPS Next 5Y22.47%
Revenue 1Y (TTM)26.3%
Revenue growth 3Y52.21%
Revenue growth 5Y60.78%
Sales Q2Q%26.02%
Revenue Next Year26.29%
Revenue Next 2Y23.9%
Revenue Next 3Y23.42%
Revenue Next 5Y23.13%
EBIT growth 1Y175.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year56.37%
EBIT Next 3Y34.34%
EBIT Next 5Y31.21%
FCF growth 1Y102.17%
FCF growth 3Y92.94%
FCF growth 5YN/A
OCF growth 1Y96.72%
OCF growth 3Y82.21%
OCF growth 5Y127.62%